Is GUTS or ELMD more profitable?

Electromed has a net margin of 11.34% compared to Fractyl Health's net margin of 0.00%. Electromed's return on equity of 15.71% beat Fractyl Health's return on equity. Company Net Margins Return on Equity Return on Assets Fractyl Health N/A -4,053.15% -96.41% Electromed 11.34% 15.71% 13.37%

Fractyl Health (GUTS) Competitors

$0.76 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$0.76 +0.00 (+0.13%)

As of 07/2/2026 07:42 PM Eastern

Compare

GUTS vs. DCTH, SI, CV, ELMD, and SGHT

Should you buy Fractyl Health stock or one of its competitors? MarketBeat compares Fractyl Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fractyl Health include Delcath Systems (DCTH), Shoulder Innovations (SI), CapsoVision (CV), Electromed (ELMD), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry.

How does Fractyl Health compare to Delcath Systems?

Fractyl Health (NASDAQ:GUTS) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

Fractyl Health presently has a consensus price target of $5.12, suggesting a potential upside of 571.92%. Delcath Systems has a consensus price target of $22.50, suggesting a potential upside of 70.45%. Given Fractyl Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Fractyl Health is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43

Delcath Systems has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	N/A	N/A	-$140.95M	-$1.29	N/A
Delcath Systems	$85.23M	5.35	$2.70M	$0.01	1,320.00

Fractyl Health has a beta of 2.29, meaning that its share price is 129% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market.

Delcath Systems has a net margin of 0.62% compared to Fractyl Health's net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Delcath Systems	0.62%	0.51%	0.46%

61.1% of Delcath Systems shares are held by institutional investors. 8.5% of Fractyl Health shares are held by insiders. Comparatively, 19.4% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Fractyl Health had 1 more articles in the media than Delcath Systems. MarketBeat recorded 1 mentions for Fractyl Health and 0 mentions for Delcath Systems. Fractyl Health's average media sentiment score of 1.00 beat Delcath Systems' score of 0.00 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Overall Sentiment
Fractyl Health	Positive
Delcath Systems	Neutral

Summary

Delcath Systems beats Fractyl Health on 10 of the 15 factors compared between the two stocks.

How does Fractyl Health compare to Shoulder Innovations?

Fractyl Health (NASDAQ:GUTS) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

Shoulder Innovations has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	N/A	N/A	-$140.95M	-$1.29	N/A
Shoulder Innovations	$53.89M	8.14	-$40.36M	-$166.96	N/A

Fractyl Health has a net margin of 0.00% compared to Shoulder Innovations' net margin of -81.78%. Shoulder Innovations' return on equity of -35.11% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

Fractyl Health currently has a consensus price target of $5.12, indicating a potential upside of 571.92%. Shoulder Innovations has a consensus price target of $21.00, indicating a potential downside of 0.74%. Given Fractyl Health's higher probable upside, equities analysts clearly believe Fractyl Health is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

In the previous week, Shoulder Innovations had 1 more articles in the media than Fractyl Health. MarketBeat recorded 2 mentions for Shoulder Innovations and 1 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 1.00 beat Shoulder Innovations' score of 0.62 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Overall Sentiment
Fractyl Health	Positive
Shoulder Innovations	Positive

Summary

Shoulder Innovations beats Fractyl Health on 8 of the 12 factors compared between the two stocks.

How does Fractyl Health compare to CapsoVision?

Fractyl Health (NASDAQ:GUTS) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

Fractyl Health has a net margin of 0.00% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
CapsoVision	-198.87%	N/A	-136.03%

In the previous week, CapsoVision had 2 more articles in the media than Fractyl Health. MarketBeat recorded 3 mentions for CapsoVision and 1 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 1.00 beat CapsoVision's score of 0.25 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Overall Sentiment
Fractyl Health	Positive
CapsoVision	Neutral

Fractyl Health presently has a consensus price target of $5.12, indicating a potential upside of 571.92%. CapsoVision has a consensus price target of $8.50, indicating a potential upside of 16.76%. Given Fractyl Health's higher probable upside, equities research analysts clearly believe Fractyl Health is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

CapsoVision has higher revenue and earnings than Fractyl Health. CapsoVision is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	N/A	N/A	-$140.95M	-$1.29	N/A
CapsoVision	$13.55M	26.84	-$25.32M	-$2.34	N/A

Summary

Fractyl Health beats CapsoVision on 7 of the 12 factors compared between the two stocks.

How does Fractyl Health compare to Electromed?

Fractyl Health (NASDAQ:GUTS) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.

Electromed has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	N/A	N/A	-$140.95M	-$1.29	N/A
Electromed	$71.75M	5.24	$5.15M	$1.17	38.83

Fractyl Health has a beta of 2.29, suggesting that its stock price is 129% more volatile than the broader market. Comparatively, Electromed has a beta of 0.5, suggesting that its stock price is 50% less volatile than the broader market.

Fractyl Health currently has a consensus target price of $5.12, indicating a potential upside of 571.92%. Electromed has a consensus target price of $37.50, indicating a potential downside of 17.46%. Given Fractyl Health's higher possible upside, equities research analysts plainly believe Fractyl Health is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

40.8% of Electromed shares are held by institutional investors. 8.5% of Fractyl Health shares are held by insiders. Comparatively, 10.5% of Electromed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Electromed has a net margin of 11.34% compared to Fractyl Health's net margin of 0.00%. Electromed's return on equity of 15.71% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Electromed	11.34%	15.71%	13.37%

In the previous week, Fractyl Health had 1 more articles in the media than Electromed. MarketBeat recorded 1 mentions for Fractyl Health and 0 mentions for Electromed. Fractyl Health's average media sentiment score of 1.00 beat Electromed's score of 0.00 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Overall Sentiment
Fractyl Health	Positive
Electromed	Neutral

Summary

Electromed beats Fractyl Health on 11 of the 16 factors compared between the two stocks.

How does Fractyl Health compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Sight Sciences currently has a consensus price target of $8.14, indicating a potential upside of 49.43%. Fractyl Health has a consensus price target of $5.12, indicating a potential upside of 571.92%. Given Fractyl Health's stronger consensus rating and higher probable upside, analysts plainly believe Fractyl Health is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Sight Sciences has a beta of 2.38, suggesting that its stock price is 138% more volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.29, suggesting that its stock price is 129% more volatile than the broader market.

Fractyl Health has a net margin of 0.00% compared to Sight Sciences' net margin of -46.83%. Sight Sciences' return on equity of -52.34% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-46.83%	-52.34%	-28.49%
Fractyl Health	N/A	-4,053.15%	-96.41%

In the previous week, Sight Sciences and Sight Sciences both had 1 articles in the media. Fractyl Health's average media sentiment score of 1.00 beat Sight Sciences' score of 0.00 indicating that Fractyl Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Sight Sciences	Neutral
Fractyl Health	Positive

Sight Sciences has higher revenue and earnings than Fractyl Health. Sight Sciences is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$77.36M	3.83	-$38.43M	-$0.71	N/A
Fractyl Health	N/A	N/A	-$140.95M	-$1.29	N/A

55.5% of Sight Sciences shares are owned by institutional investors. 30.9% of Sight Sciences shares are owned by insiders. Comparatively, 8.5% of Fractyl Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Sight Sciences beats Fractyl Health on 9 of the 14 factors compared between the two stocks.

Get Fractyl Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GUTS vs. The Competition

Export

Metric	Fractyl Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$120.89M	$3.10B	$7.18B	$12.48B
Dividend Yield	N/A	2.05%	2.66%	6.51%
P/E Ratio	-0.59	20.06	28.02	24.70
Price / Sales	N/A	357.01	538.99	99.06
Price / Cash	N/A	57.49	49.26	57.09
Price / Book	10.89	4.32	10.96	6.46
Net Income	-$140.95M	$64.45M	$3.57B	$337.01M
7 Day Performance	2.56%	2.97%	2.12%	1.69%
1 Month Performance	12.29%	6.83%	5.25%	3.81%
1 Year Performance	-53.39%	29.07%	33.29%	23.90%

Fractyl Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GUTS Fractyl Health	4.3627 of 5 stars	$0.76 flat	$5.12 +571.9%	-53.4%	$120.89M	N/A	N/A	102	Positive News Analyst Forecast Gap Up
DCTH Delcath Systems	1.6132 of 5 stars	$12.66 -2.2%	$22.50 +77.7%	+3.7%	$437.05M	$90.44M	1,266.00	60	Gap Down
SI Shoulder Innovations	2.2349 of 5 stars	$20.70 -9.2%	$21.00 +1.4%	N/A	$429.40M	$47.32M	N/A	61
CV CapsoVision	1.1308 of 5 stars	$7.37 -1.9%	$8.50 +15.3%	N/A	$367.96M	$13.55M	N/A	90	News Coverage
ELMD Electromed	0.6936 of 5 stars	$42.06 -0.4%	$37.50 -10.8%	+118.6%	$348.26M	$71.75M	56.08	160	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GUTS) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fractyl Health (GUTS) Competitors

GUTS vs. DCTH, SI, CV, ELMD, and SGHT

How does Fractyl Health compare to Delcath Systems?

Summary

How does Fractyl Health compare to Shoulder Innovations?

Summary

How does Fractyl Health compare to CapsoVision?

Summary

How does Fractyl Health compare to Electromed?

Summary

How does Fractyl Health compare to Sight Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS vs. The Competition

Fractyl Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fractyl Health (GUTS) Competitors

GUTS vs. DCTH, SI, CV, ELMD, and SGHT

How does Fractyl Health compare to Delcath Systems?

Do analysts recommend GUTS or DCTH?

Which has stronger earnings and valuation, GUTS or DCTH?

Which has more volatility & risk, GUTS or DCTH?

Is GUTS or DCTH more profitable?

Do institutionals & insiders believe in GUTS or DCTH?

Does the media prefer GUTS or DCTH?

Summary

How does Fractyl Health compare to Shoulder Innovations?

Which has preferable earnings & valuation, GUTS or SI?

Is GUTS or SI more profitable?

Do analysts recommend GUTS or SI?

Does the media prefer GUTS or SI?

Summary

How does Fractyl Health compare to CapsoVision?

Is GUTS or CV more profitable?

Does the media prefer GUTS or CV?

Do analysts recommend GUTS or CV?

Which has stronger valuation & earnings, GUTS or CV?

Summary

How does Fractyl Health compare to Electromed?

Which has better earnings and valuation, GUTS or ELMD?

Which has more volatility & risk, GUTS or ELMD?

Do analysts recommend GUTS or ELMD?

Do insiders & institutionals have more ownership in GUTS or ELMD?

Is GUTS or ELMD more profitable?

Does the media prefer GUTS or ELMD?

Summary

How does Fractyl Health compare to Sight Sciences?

Do analysts rate SGHT or GUTS?

Which has more risk & volatility, SGHT or GUTS?

Is SGHT or GUTS more profitable?

Does the media prefer SGHT or GUTS?

Which has preferable earnings and valuation, SGHT or GUTS?

Do institutionals and insiders have more ownership in SGHT or GUTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS vs. The Competition

Fractyl Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools